Company Filing History:
Years Active: 2018
Title: Peter Gengo: Innovator in Cardiovascular Treatments
Introduction
Peter Gengo is a notable inventor based in Carlsbad, CA (US). He has made significant contributions to the field of cardiovascular medicine through his innovative research and development of novel peptides. His work focuses on the treatment and prevention of conditions related to the corticotrophin releasing hormone receptor type 2 (CRHR2).
Latest Patents
Peter Gengo holds a patent for "CRHR2 peptide agonists and uses thereof." This invention relates to novel peptides that are selective CRHR2 agonists and compositions for treating cardiovascular conditions, including heart failure. The patent emphasizes the use of pegylated peptides and outlines methods for treating diseases associated with CRHR2 activity. He has 1 patent to his name.
Career Highlights
Gengo's career is marked by his dedication to advancing medical science. He works at Janssen Pharmaceutica NV, where he collaborates with other experts in the field to develop innovative solutions for cardiovascular health. His research has the potential to significantly impact patient care and treatment outcomes.
Collaborations
Peter Gengo has worked alongside notable colleagues, including Ronald V. Swanson and Nigel P. Shankley. Their combined expertise contributes to the advancement of research in the pharmaceutical industry.
Conclusion
Peter Gengo is a distinguished inventor whose work in developing CRHR2 peptide agonists showcases his commitment to improving cardiovascular treatments. His contributions to the field are invaluable and hold promise for future medical advancements.